Literature DB >> 16405928

A species-specific difference in the effects of harmaline on the rodent olivocerebellar system.

Hideto Miwa1, Tomomi Kubo, Ai Suzuki, Tameko Kihira, Tomoyoshi Kondo.   

Abstract

The rodent model of harmaline-induced tremor has been widely used for experimental analysis of tremor. Activation of the olivocerebellar system plays a key role in tremor-generating mechanisms. One undetermined problem is whether there are species-specific differences in effects of harmaline. The present study investigated effects of harmaline on olivocerebellar systems of mice and rats. Systemic administration of harmaline, but not vehicle, produced generalized, high-frequency tremors in both types of rodents. Immunohistochemical studies revealed significant degeneration of Purkinje cells that was associated with activated microgliosis in the cerebellar cortex, following administration of harmaline in rats but not in mice. However, in mice but not rats, microgliosis was induced following administration of harmaline in the inferior olivary nucleus (ION), particularly in its caudal and medial subdivisions. Numbers of neurons in the mouse ION did not decrease, suggesting the possibility that microgliosis in ION might not be a simple neurotoxic effect. Presumably, differences in sensitivity of Purkinje cells between rats and mice may be related to differences in functional alterations in their respective olivocerebellar systems induced by harmaline. Recognition of these species-specific differences in the response of the olivocerebellar system to harmaline is an important consideration for experimental analysis of the rodent model of tremors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16405928     DOI: 10.1016/j.brainres.2005.11.036

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

Review 1.  Cell death as a regulator of cerebellar histogenesis and compartmentation.

Authors:  Jakob Jankowski; Andreas Miething; Karl Schilling; John Oberdick; Stephan Baader
Journal:  Cerebellum       Date:  2011-09       Impact factor: 3.847

Review 2.  [Pathophysiology of tremor].

Authors:  M Muthuraman; A Schnitzler; S Groppa
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

Review 3.  Banisteriopsis caapi, a Forgotten Potential Therapy for Parkinson's Disease?

Authors:  Atbin Djamshidian; Sabine Bernschneider-Reif; Werner Poewe; Andrew J Lees
Journal:  Mov Disord Clin Pract       Date:  2015-10-06

4.  Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat.

Authors:  Hassan Abbassian; Benjamin J Whalley; Vahid Sheibani; Mohammad Shabani
Journal:  Br J Pharmacol       Date:  2016-10-04       Impact factor: 8.739

5.  Remodeling of monoplanar Purkinje cell dendrites during cerebellar circuit formation.

Authors:  Megumi Kaneko; Kazuhiko Yamaguchi; Mototsugu Eiraku; Motohiko Sato; Norio Takata; Yoshimoto Kiyohara; Masayoshi Mishina; Hajime Hirase; Tsutomu Hashikawa; Mineko Kengaku
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

6.  Harmaline-induced tremor in mice: videotape documentation and open questions about the model.

Authors:  Melody M Cheng; Guomei Tang; Sheng-Han Kuo
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-12-09

7.  Development of Harmaline-induced Tremor in a Swine Model.

Authors:  Jihyun Lee; Inyong Kim; Jeyeon Lee; Emily Knight; Lei Cheng; Shin Il Kang; Dong Pyo Jang; Su-Youne Chang
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-03-13

8.  Harmaline tremor: underlying mechanisms in a potential animal model of essential tremor.

Authors:  Adrian Handforth
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-09-12

Review 9.  Rodent models of tremor.

Authors:  Hideto Miwa
Journal:  Cerebellum       Date:  2007       Impact factor: 3.648

10.  Tremorgenesis: a new conceptual scheme using reciprocally innervated circuit of neurons.

Authors:  Mario Manto
Journal:  J Transl Med       Date:  2008-11-26       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.